Clinical Trial Update: Phase I Trial of Intratumoral pIL-12 Electroporation in Malignant Melanoma [NA]

View source ↗

Summary

Completed Phase I trial evaluating intratumoral delivery of an interleukin-12 plasmid (pIL-12) by electroporation in malignant melanoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Melanoma

Drugs mentioned

• pIL-12 intratumoral electroporation (interleukin-12 plasmid (pIL-12))

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Malignant Melanoma | NA | Status: COMPLETED